Cancer frequently metastasizes to the brain, and such lesions, whether multiple or solitary, have a poor prognosis, despite all efforts to treat them. There have been recent sporadic reports of brain metastases from breast cancer responding for some years to antiestrogens (particularly tamoxifen) or bromocryptine. We report three cases of brain metastasis from cancer – two multiple and one a solitary lesion. The long survival of the patients – two for 5 years and one for 6 years, with more than an acceptable quality of life – should prompt therapeutic trials to test tamoxifen and designed to assess its effects on a sizable number of patients.
BatzdorfU., BlackK.L., SelchM.T.: Neoplasm of the nervous system. In: Cancer Treament.HaskellC.M. (Ed.), pp. 436–474. Third edition, W.B. Saunders, Philadelphia, 1990.
2.
CareyR.W., DavisJ.M., ZervasN.T.: Tamoxifen-induced regression of cerebral metastases in breast carcinoma. Cancer Treat. Rep., 65: 793–795, 1981.
3.
ColomerR., CasasD., Del CampoJ.M., BoadaM., RubioD., SalvadorL.: Brain metastases form breast carcinoma may respond to endocrine therapy. Breast Cancer Res. Treat., 12: 83–86, 1988.
4.
GalícichJ.H., ArbitE.: Metastatic brain tumors. In: Neurological Surgery.YuomansJ.R. (Ed.), pp. 3204–3222. Third edition. WB Saunders, Philadelphia, 1990.
5.
GrisoliF., VincentelliF., FoaJ., LavailG., SalamonG.: Effect of bromocriptine on brain metastasis in breast cancer. Lancet, 2: 745–746, 1981.
6.
HansenS.B., GalsgardH., von EybenF.E., Westergard-NielsenV., Wolf-JensenJ.: Tamoxifen for brain metastasis from breast cancer. Ann. Neurol., 20: 544, 1986.
7.
HendersonI.C., HarrisJ.A., KinneD.W., HellmanS.: Cancer of the breast. In: Cancer. Principles and Practice of Oncology.De VitaV.T.Jr., HellmanS., RosenbergS.A. (Eds.), pp. 1197–1268. Third edition, Lippincott, Philadelphia, 1989.
8.
KarnofskyD.A., BurchenalJ.H.: The clinical evaluation of chemotherapeutic agents. In: Evaluation of Chemotherapeutic Agents.MacLeod (Ed.), pp. 191–205, Columbia University Press, New York, 1949.
9.
KryscioH., MarkesberryW.R., MacDonaldJ.S., YoungB.: A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med., 322: 494–500, 1990.
10.
LienE.A., WesterK., LonningP.E., SolheimE., UelandP.M.: Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients. Br. J. Cancer, 63: 641–645, 1991.
PorsH., von EybenF.E., SorensenO.S., LarsenM.: Long-term remission of multiple brain metastases with tamoxifen. J. Neuroncol., 10: 173–177, 1991.
13.
RussellD.S., RubinsteinL.J.: Secondary tumor of the central nervous system. In: Pathology of tumors of the nervous system.RussellD.S., RubinsteinL.J. (Eds.), pp. 809–854. Fifth edition, Edward Arnold, London, 1989.
14.
SwainS.M., LippmanM.E.: Endocrine therapies of cancer. In: Cancer Chemotherapy. Principles and Practice.ChabnerB.A., CollinsJ.M. (Eds.), pp. 59–109, Lippincott Comp., Philadelphia, 1992.
15.
TominagaT.: Characteristics and treatments of metastases to central nervous system in patients with breast cancer. Jap. J. Cancer Clin., 30: 987–993, 1984.
16.
TsukadaY., FouadA., PickrenJ.W., LanneW.W.: Central nervous system metastasis from breast carcinoma: autopsy study. Cancer, 52: 2349–2354, 1983.
17.
WrightD.C., DelaneyT.F.: Treatment of metastatic cancer to the brain. In: Cancer. Principles and Practice of Oncology.De VitaV.T.Jr., HellmanS., RosenbergS.A. (Eds.), pp. 2254–2261. Third edition, Lippincott, Philadelphia, 1989.
